Free tool
Oncology stocks
We cover 11 companies grouped under the Oncology theme. The median market value in the group is $253.56M. Across the group, the median move over the past trading day is +0.41%. Price change over the past year runs from −11.3% to +346.3% across the middle 80 percent of the group, with a median of +22.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
11 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% | Oct 8, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.12B | Mid cap | +341.09% | Sep 29, 2026 |
| NBTX | Nanobiotix S.A. | $2.11B | Mid cap | +321.42% | Sep 29, 2026 |
| 0QAV.L | Nanobiotix S.A. | $671.98M | Small cap | +346.30% | Sep 29, 2026 |
| PRTC.L | PureTech Health plc | $402.61M | Small cap | −11.34% | Aug 27, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +1.34% | Sep 17, 2026 |
| IDD.DE | Innate Pharma S.A. | $247.30M | Small cap | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $244.95M | Small cap | +1.84% | Sep 17, 2026 |
| BINV.ST | BioInvent International AB (publ) | $169.15M | Small cap | −24.30% | Aug 27, 2026 |
| 0RU5.L | Oncoinvent ASA | $128.23M | Small cap | +5951.72% | Aug 27, 2026 |
| ANIX | Anixa Biosciences, Inc. | $123.16M | Small cap | +22.00% | Sep 9, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.